Maryam Lustberg, MD, MPH
Maryam Lustberg, MD, MPH, has been appointed Director of The Breast Center at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center. She will also join the faculty at Yale Cancer Center as Associate Professor of Medicine (Medical Oncology).
Dr. Lustberg joins Yale from The Ohio State University, where she is Associate Professor in the Division of Medical Oncology at The James, Director of its Breast Cancer Survivorship Program, and Medical Director of Supportive Care. She has been recognized for her patient-focused care, with awards that include being rated by Forbes as one of the top breast medical oncologists in the nation and named to the Castle Connolly list of Regional Top Doctors and Exceptional Women in Medicine for 2020. She is currently participating in the ASCO Leadership Development Program.
With an emphasis on improving the long-term outcomes for patients with breast cancer who have developed side effects associated with treatment, Dr. Lustberg will continue her research efforts at Yale. She is also investigating novel blood-based biomarkers to identify recurrence and treatment toxicity earlier. She is a National Cancer Institute–funded investigator and active in both -ALLIANCE and SWOG Cancer Cooperative Groups. Dr. Lustberg collaborates widely with researchers from around the world, thriving in creating innovative multidisciplinary scientific teams.
Roy S. Herbst, MD, PhD
“Dr. Lustberg’s experience in breast treatment and leadership in outcomes and patient-focused care will be an incredible advantage to both our patient care and research efforts, as we continue to expand our breast cancer initiatives at Yale Cancer Center and Smilow Cancer Hospital,” said Roy S. Herbst, MD, PhD, Chief of Medical Oncology, Ensign Professor of Medicine (Medical Oncology), and Professor of Pharmacology, and Associate Cancer Center Director for Translational Research at Yale Cancer Center and Smilow Cancer Hospital.